SCHEMBL6479515

SCHEMBL6479515

Cc1ccccc1C=Cc1ccc(-c2ccc(C=Cc3ccccc3C)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.61
KDM4E B2RXH2 1/20 0.61
APOBEC3A P31941 1/20 0.61
APOBEC3G Q9HC16 1/20 0.61
NFE2L2 Q16236 9/20 0.50
TSHR P16473 2/20 0.46
ALDH1A1 P00352 1/20 0.46
FGF23 Q9GZV9 1/20 0.46
CHAT P28329 1/20 0.46
MEN1 O00255 1/20 0.46
PABPC1 P11940 1/20 0.46
KMT2A Q03164 1/20 0.46
CYP1A2 P05177 2/20 0.43
TP53 P04637 1/20 0.43
CYP2D6 P10635 1/20 0.43
THPO P40225 1/20 0.43
HIF1A Q16665 1/20 0.43
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
TRPA1 O75762 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479514 1.00 RAB9A (0.61) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL318135 0.93 RAB9A (0.68) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL29403804 0.93 RAB9A (0.68) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL142258 0.93 RAB9A (0.68) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL16105486 0.87 NFE2L2 (0.66) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL16105485 0.87 NFE2L2 (0.66) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL16105484 0.87 NFE2L2 (0.66) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL1128126 0.86 RAB9A (0.66) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL16105782 0.86 RAB9A (0.66) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2
SCHEMBL1128128 0.86 RAB9A (0.66) RAB9AKDM4EAPOBEC3AAPOBEC3GNFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050096491-A1 Aromatic methylidene compound, methylstyryl compound for producing the same, production method therefor, and organic electroluminescent element MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-05-05 US disclosed
US-20030224206-A1 Aromatic methylidene compound, methylstyryl compound for producing the same, production method therefor, and organic electroluminescent element MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2003-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096491-A1 Aromatic methylidene compound, methylstyryl compound for producing the same, production method therefor, and organic electroluminescent element OR51E2, CYP4F11, ACAD11 RAB9A 3751/4885KDM4E 909/4885APOBEC3A 4081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.